Below are the most recent publications written about "Fatty Acids" by people in Profiles.
-
Zhu B, Zhu X, Borland MG, Ralph DH, Chiaro CR, Krausz KW, Ntambi JM, Glick AB, Patterson AD, Perdew GH, Gonzalez FJ, Peters JM. Activation of Peroxisome Proliferator-Activated Receptor-?/d (PPAR?/d) in Keratinocytes by Endogenous Fatty Acids. Biomolecules. 2024 May 21; 14(6).
-
Summer R, Todd JL, Neely ML, Lobo LJ, Namen A, Newby LK, Shafazand S, Suliman S, Hesslinger C, Keller S, Leonard TB, Palmer SM, Ilkayeva O, Muehlbauer MJ, Newgard CB, Roman J. Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. Respir Res. 2024 Jan 25; 25(1):58.
-
Gambari L, Cellamare A, Grassi F, Grigolo B, Panciera A, Ruffilli A, Faldini C, Desando G. Targeting the Inflammatory Hallmarks of Obesity-Associated Osteoarthritis: Towards Nutraceutical-Oriented Preventive and Complementary Therapeutic Strategies Based on n-3 Polyunsaturated Fatty Acids. Int J Mol Sci. 2023 May 26; 24(11).
-
Yamaguchi A, van Hoorebeke C, Tourdot BE, Perry SC, Lee G, Rhoads N, Rickenberg A, Green AR, Sorrentino J, Yeung J, Freedman JC, Holman TR, Holinstat M. Fatty acids negatively regulate platelet function through formation of noncanonical 15-lipoxygenase-derived eicosanoids. Pharmacol Res Perspect. 2023 Feb; 11(1):e01056.
-
Serrano E, Whitaker-Menezes D, Lin Z, Roche M, Martinez Cantarin MP. Uremic Myopathy and Mitochondrial Dysfunction in Kidney Disease. Int J Mol Sci. 2022 Nov 04; 23(21).
-
Yan Y, Huang L, Liu Y, Yi M, Chu Q, Jiao D, Wu K. Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity. J Hematol Oncol. 2022 08 10; 15(1):104.
-
Patil NY, Rus I, Downing E, Mandala A, Friedman JE, Joshi AD. Cinnabarinic Acid Provides Hepatoprotection Against Nonalcoholic Fatty Liver Disease. J Pharmacol Exp Ther. 2022 10; 383(1):32-43.
-
Moellmann J, Mann PA, Kappel BA, Kahles F, Klinkhammer BM, Boor P, Kramann R, Ghesquiere B, Lebherz C, Marx N, Lehrke M. The sodium-glucose co-transporter-2 inhibitor ertugliflozin modifies the signature of cardiac substrate metabolism and reduces cardiac mTOR signalling, endoplasmic reticulum stress and apoptosis. Diabetes Obes Metab. 2022 11; 24(11):2263-2272.
-
Mitzscherling J, MacLean J, Lipus D, Bartholom?us A, Mangelsdorf K, Lipski A, Roddatis V, Liebner S, Wagner D. Paenalcaligenes niemegkensis sp. nov., a novel species of the family Alcaligenaceae isolated from plastic waste. Int J Syst Evol Microbiol. 2022 Apr; 71(4).
-
Mitzscherling J, MacLean J, Lipus D, Bartholom?us A, Mangelsdorf K, Lipski A, Roddatis V, Liebner S, Wagner D. Nocardioides alcanivorans sp. nov., a novel hexadecane-degrading species isolated from plastic waste. Int J Syst Evol Microbiol. 2022 Apr; 72(4).